AI vs. cancer: AstraZeneca exec reveals how COVID pandemic h

AstraZeneca's Dave Fredrickson said he expects large advances in blood-based screening and AI-assisted cancer diagnosis and treatment by the year 2040.

Related Keywords

David Fredrickson , Nikolas Lanum , Astrazeneca , Milken Institute Global Conference , Executive Vice President , Oncology Business Unit , Fox News Digital , Astrazeneca Oncology United Kingdom , Oncology Data Science , Fox News ,